CHINA KANGTAI CACTUS BIO-TECH ehemals INVESTNET - 500 Beiträge pro Seite
eröffnet am 26.01.07 14:18:25 von
neuester Beitrag 29.01.07 20:23:57 von
neuester Beitrag 29.01.07 20:23:57 von
Beiträge: 6
ID: 1.107.682
ID: 1.107.682
Aufrufe heute: 0
Gesamt: 621
Gesamt: 621
Aktive User: 0
Top-Diskussionen
Titel | letzter Beitrag | Aufrufe |
---|---|---|
gestern 18:41 | 236 | |
heute 00:26 | 154 | |
22.06.20, 20:50 | 149 | |
gestern 23:55 | 126 | |
gestern 22:49 | 98 | |
heute 02:54 | 85 | |
04.02.24, 15:01 | 75 | |
gestern 23:37 | 74 |
Meistdiskutierte Wertpapiere
Platz | vorher | Wertpapier | Kurs | Perf. % | Anzahl | ||
---|---|---|---|---|---|---|---|
1. | 1. | 18.002,02 | -1,44 | 264 | |||
2. | 2. | 26,58 | -0,63 | 137 | |||
3. | 3. | 178,01 | -2,44 | 77 | |||
4. | Neu! | 479,00 | -5,71 | 69 | |||
5. | 6. | 0,1855 | -1,85 | 67 | |||
6. | 15. | 17,550 | -4,10 | 63 | |||
7. | 5. | 131,88 | +1,75 | 48 | |||
8. | 18. | 5,2900 | -1,89 | 43 |
Vielleicht ist das Geld ja doch nicht ganz verbrannt das wir vor jahren in Investnet investiert haben. Gibt es ausser mir noch andere, die noch immer nicht ganz freiwillig in china kangtai cactus investiert sind. Die letzten provisorischen zahlen sehen gar nicht so schlecht aus und vielleicht haben wir plötzlich einen tenbagger???
Lasst mal hören, wer noch investiert ist und ob ihr eine meinung zu der firma habt......
cu Ludmilla
China Kangtai Cactus Biotech Announces Preliminary Year End 2006 Results
Monday January 22, 4:31 pm ET
Net Sales Increase 110%; Net Income Grows Over 300%
HARBIN, China, Jan. 22 /Xinhua-PRNewswire-FirstCall/ -- China Kangtai Cactus Biotech, Inc. (OTC Bulletin Board: CKGT - News), a vertically integrated grower, developer, manufacturer and marketer of a variety of cactus-based consumer products, today reported preliminary, unaudited results for the year ended December 31, 2006. All estimated results reported are in U.S. dollars. The preliminary unaudited results indicate that net sales for the year-ended December 31, 2006 will increase to approximately $17 million, which would represent an increase of approximately 110% as compared to net sales of $8 million for the year ended December 31, 2005. The preliminary unaudited results also indicate that net income from operations for the year ended December 31, 2006 will increase to approximately $3.4 million, which would represent an increase of more than 300% over net income from operations of $795,000 for the year ended December 31, 2005. Final audited results are expected to be reported in mid-February.
ADVERTISEMENT
Jinjiang Wang, Chief Executive Officer of China Kangtai Cactus Biotech commented,
Lasst mal hören, wer noch investiert ist und ob ihr eine meinung zu der firma habt......
cu Ludmilla
China Kangtai Cactus Biotech Announces Preliminary Year End 2006 Results
Monday January 22, 4:31 pm ET
Net Sales Increase 110%; Net Income Grows Over 300%
HARBIN, China, Jan. 22 /Xinhua-PRNewswire-FirstCall/ -- China Kangtai Cactus Biotech, Inc. (OTC Bulletin Board: CKGT - News), a vertically integrated grower, developer, manufacturer and marketer of a variety of cactus-based consumer products, today reported preliminary, unaudited results for the year ended December 31, 2006. All estimated results reported are in U.S. dollars. The preliminary unaudited results indicate that net sales for the year-ended December 31, 2006 will increase to approximately $17 million, which would represent an increase of approximately 110% as compared to net sales of $8 million for the year ended December 31, 2005. The preliminary unaudited results also indicate that net income from operations for the year ended December 31, 2006 will increase to approximately $3.4 million, which would represent an increase of more than 300% over net income from operations of $795,000 for the year ended December 31, 2005. Final audited results are expected to be reported in mid-February.
ADVERTISEMENT
Jinjiang Wang, Chief Executive Officer of China Kangtai Cactus Biotech commented,
Antwort auf Beitrag Nr.: 27.198.665 von Ludmilla am 26.01.07 14:18:25ja ich. lol.
ich hab so für 8 € China Kangtai Cactus zeug im Depot :-)
Verkaufen lohnt bei der summe eh nicht.
gruss
billy
ich hab so für 8 € China Kangtai Cactus zeug im Depot :-)
Verkaufen lohnt bei der summe eh nicht.
gruss
billy
Antwort auf Beitrag Nr.: 27.231.639 von BillyT. am 27.01.07 20:42:35ein bisschen mehr ist es bei mir im depot schon noch, schaun wir mal ob es mehr wird.....
cu Ludmilla
cu Ludmilla
China Kangtai Cactus Biotech Announces Preliminary Year End 2006 Results
Net Sales Increase 110%; Net Income Grows Over 300%
HARBIN, China, Jan. 22 /Xinhua-PRNewswire-FirstCall/ -- China Kangtai Cactus Biotech, Inc. (OTC Bulletin Board: CKGT), a vertically integrated grower, developer, manufacturer and marketer of a variety of cactus-based consumer products, today reported preliminary, unaudited results for the year ended December 31, 2006. All estimated results reported are in U.S. dollars. The preliminary unaudited results indicate that net sales for the year-ended December 31, 2006 will increase to approximately $17 million, which would represent an increase of approximately 110% as compared to net sales of $8 million for the year ended December 31, 2005. The preliminary unaudited results also indicate that net income from operations for the year ended December 31, 2006 will increase to approximately $3.4 million, which would represent an increase of more than 300% over net income from operations of $795,000 for the year ended December 31, 2005. Final audited results are expected to be reported in mid-February.
Jinjiang Wang, Chief Executive Officer of China Kangtai Cactus Biotech commented, 'Our projected revenue growth for 2006 is attributed to a growing demand for our high quality cactus-based consumer products throughout China, as well as our continuing efforts to expand our growing distribution network.'
Wang concluded, 'Our Company remains focused on creating more product categories and lines for distribution and enhancing our sales support as well as our inventory management systems. With 17 product patents and 15 pending approval, China Kangtai is the dominant company in the cactus-based consumer product sector.'
About China Kangtai Cactus Bio-Tech Inc.
China Kangtai Cactus Bio-Tech Inc. is market-leading cactus grower and producer of cactus-related products with over 520 acres of plants and an active R&D group that holds 17 product patents and is seeking another 15 in a variety of product categories. Kangtai's high-quality products are sold throughout China through a growing distribution network that includes franchised, company-owned and third party stores, as well as store counters in supermarkets, department stores, hotels, restaurants and malls.
Cautionary Statement Regarding Forward Looking Information
This press release contains forward-looking information about China Kangtai Cactus Bio-tech that is intended to be covered by the safe harbor for forward-looking statements provided by the Private Securities Litigation Reform Act of 1995. Forward-looking statements are statements that are not historical facts. These statements can be identified by the use of forward- looking terminology such as 'believe,' 'expect,' 'may,' 'will,' 'should,' 'project,' 'plan,' 'seek,' 'intend,' or 'anticipate' or the negative thereof or comparable terminology, and include discussions of strategy, and statements about industry trends and China Kangtai Cactus Bio-tech future performance, operations and products.
This forward-looking information should be considered only in connection with 'Risk Factors' in China Kangtai Cactus Bio-tech's quarterly report on Form 10-Q filed with the SEC on November 14, 2006, and its other current and periodic reports filed with the SEC. China Kangtai Cactus Bio-tech assumes no obligations to update any forward-looking statements or information set forth in this press release.
Contact:
Ren Hu Adam Friedman
China Kangtai Cactus Bio-tech, Inc. Adam Friedman Associates
Arenhu@gmail.com adam@adam-friedman.com
201-887-0415 212-981-2529 ext. 18
SOURCE China Kangtai Cactus Biotech, Inc.
Source: PR Newswire (January 22, 2007 - 4:31 PM EST)
News by QuoteMedia
www.quotemedia.com
Net Sales Increase 110%; Net Income Grows Over 300%
HARBIN, China, Jan. 22 /Xinhua-PRNewswire-FirstCall/ -- China Kangtai Cactus Biotech, Inc. (OTC Bulletin Board: CKGT), a vertically integrated grower, developer, manufacturer and marketer of a variety of cactus-based consumer products, today reported preliminary, unaudited results for the year ended December 31, 2006. All estimated results reported are in U.S. dollars. The preliminary unaudited results indicate that net sales for the year-ended December 31, 2006 will increase to approximately $17 million, which would represent an increase of approximately 110% as compared to net sales of $8 million for the year ended December 31, 2005. The preliminary unaudited results also indicate that net income from operations for the year ended December 31, 2006 will increase to approximately $3.4 million, which would represent an increase of more than 300% over net income from operations of $795,000 for the year ended December 31, 2005. Final audited results are expected to be reported in mid-February.
Jinjiang Wang, Chief Executive Officer of China Kangtai Cactus Biotech commented, 'Our projected revenue growth for 2006 is attributed to a growing demand for our high quality cactus-based consumer products throughout China, as well as our continuing efforts to expand our growing distribution network.'
Wang concluded, 'Our Company remains focused on creating more product categories and lines for distribution and enhancing our sales support as well as our inventory management systems. With 17 product patents and 15 pending approval, China Kangtai is the dominant company in the cactus-based consumer product sector.'
About China Kangtai Cactus Bio-Tech Inc.
China Kangtai Cactus Bio-Tech Inc. is market-leading cactus grower and producer of cactus-related products with over 520 acres of plants and an active R&D group that holds 17 product patents and is seeking another 15 in a variety of product categories. Kangtai's high-quality products are sold throughout China through a growing distribution network that includes franchised, company-owned and third party stores, as well as store counters in supermarkets, department stores, hotels, restaurants and malls.
Cautionary Statement Regarding Forward Looking Information
This press release contains forward-looking information about China Kangtai Cactus Bio-tech that is intended to be covered by the safe harbor for forward-looking statements provided by the Private Securities Litigation Reform Act of 1995. Forward-looking statements are statements that are not historical facts. These statements can be identified by the use of forward- looking terminology such as 'believe,' 'expect,' 'may,' 'will,' 'should,' 'project,' 'plan,' 'seek,' 'intend,' or 'anticipate' or the negative thereof or comparable terminology, and include discussions of strategy, and statements about industry trends and China Kangtai Cactus Bio-tech future performance, operations and products.
This forward-looking information should be considered only in connection with 'Risk Factors' in China Kangtai Cactus Bio-tech's quarterly report on Form 10-Q filed with the SEC on November 14, 2006, and its other current and periodic reports filed with the SEC. China Kangtai Cactus Bio-tech assumes no obligations to update any forward-looking statements or information set forth in this press release.
Contact:
Ren Hu Adam Friedman
China Kangtai Cactus Bio-tech, Inc. Adam Friedman Associates
Arenhu@gmail.com adam@adam-friedman.com
201-887-0415 212-981-2529 ext. 18
SOURCE China Kangtai Cactus Biotech, Inc.
Source: PR Newswire (January 22, 2007 - 4:31 PM EST)
News by QuoteMedia
www.quotemedia.com
Richtung norden.....12%.....
mal schauen was aus dem teil wird.
cu Ludmilla
mal schauen was aus dem teil wird.
cu Ludmilla
Antwort auf Beitrag Nr.: 27.276.339 von Ludmilla am 29.01.07 17:31:55kratzt und schabt an der 2$ marke...
cu Ludmilla
cu Ludmilla
Beitrag zu dieser Diskussion schreiben
Zu dieser Diskussion können keine Beiträge mehr verfasst werden, da der letzte Beitrag vor mehr als zwei Jahren verfasst wurde und die Diskussion daraufhin archiviert wurde.
Bitte wenden Sie sich an feedback@wallstreet-online.de und erfragen Sie die Reaktivierung der Diskussion oder starten Sie eine neue Diskussion.
Meistdiskutiert
Wertpapier | Beiträge | |
---|---|---|
59 | ||
37 | ||
19 | ||
18 | ||
18 | ||
17 | ||
17 | ||
15 | ||
14 | ||
14 |
Wertpapier | Beiträge | |
---|---|---|
13 | ||
12 | ||
12 | ||
11 | ||
11 | ||
11 | ||
11 | ||
10 | ||
10 | ||
10 |